Vandetanib in Advanced Medullary Thyroid Cancer: Review of Adverse Event Management Strategies

被引：0
|
作者：
Enrique Grande
Michael C. Kreissl
Sebastiano Filetti
Kate Newbold
Walter Reinisch
Caroline Robert
Martin Schlumberger
Lærke K. Tolstrup
Jose L. Zamorano
Jaume Capdevila
机构：
[1] Hospital Ramón y Cajal,Servicio de Oncología Médica
[2] University Hospital of Wuerzburg,Department of Nuclear Medicine
[3] Central Hospital of Augsburg,Department of Nuclear Medicine
[4] University of Rome “Sapienza”,Department of Internal Medicine and Medical Specialities
[5] Royal Marsden Hospital,Thyroid Unit
[6] Medical University of Vienna,Division of Gastroenterology and Hepatology, Department of Internal Medicine III
[7] University of Paris-Sud,Department of Medical Oncology, Dermatology Unit and INSERM U981, Gustave Roussy Institute
[8] University of Paris-Sud,Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute
[9] Odense University Hospital,Department of Oncology, Clinical Research Unit
[10] Hospital Ramón y Cajal,Cardiology Service
[11] Vall d’Hebron University Hospital,Medical Oncology Department, Gastrointestinal and Endocrine Tumor Unit
[12] Autonomous University of Barcelona,undefined
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Adverse effects; Antineoplastic agents/adverse effects; Cardiovascular; Dermatology; Medullary thyroid cancer; Medullary thyroid carcinoma; Patient safety; Piperidines/therapeutic use; Protein kinase inhibitors; Thyroid neoplasms/drug therapy; Vandetanib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：945 / 966
页数：21
相关论文
共 50 条
  • [31] Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
    Milling, Rikke Vilsboll
    Grimm, Daniela
    Krueger, Marcus
    Grosse, Jirka
    Kopp, Sascha
    Bauer, Johann
    Infanger, Manfred
    Wehland, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [32] Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma
    Durante, Cosimo
    Paciaroni, Alessandra
    Plasmati, Katia
    Trulli, Fabiana
    Filetti, Sebastiano
    ENDOCRINE, 2013, 44 (02) : 334 - 342
  • [33] Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma
    Cosimo Durante
    Alessandra Paciaroni
    Katia Plasmati
    Fabiana Trulli
    Sebastiano Filetti
    Endocrine, 2013, 44 : 334 - 342
  • [34] An Unusual Case of Hypopituitarism as an Adverse Effect of Vandetanib and Remission of Breast Metastases in a Patient with Medullary Thyroid Cancer
    Garcia-Moreno, Rosa M.
    Moreno-Dominguez, Oscar
    Castelo-Fernandez, Beatriz
    Yebenes-Gregorio, Laura
    Torres-Sanchez, Isabel
    Alvarez-Escola, Cristina
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (10) : 568 - 572
  • [35] The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer
    Fallahi, Poupak
    Ferrari, Silvia Martina
    Baldini, Enke
    Biricotti, Marco
    Ulisse, Salvatore
    Materazzi, Gabriele
    Miccoli, Paolo
    Antonelli, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (11) : 1109 - 1118
  • [36] Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer
    Bastholt, Lars
    Kreissl, Michael C.
    Fuehrer, Dagmar
    Maia, Ana L.
    Locati, Laura D.
    Maciel, Lea
    Wu, Yi
    Heller, Kevin N.
    Webster, Alan
    Elisei, Rossella
    EUROPEAN THYROID JOURNAL, 2016, 5 (03) : 187 - 194
  • [37] Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
    Deshpande, Hari
    Roman, Sanziana
    Thumar, Jaykumar
    Sosa, Julie Ann
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 213 - 221
  • [38] Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer
    Nix, PA
    Nicolaides, A
    Coatesworth, AP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 80 - 84
  • [39] Combination Therapy of Medullary Thyroid Cancer Using Radiation and Vandetanib
    Sandblom, V.
    Spetz, J.
    Shubbar, E.
    Swanpalmer, J.
    Forssell-Aronsson, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S768 - S768
  • [40] Vandetanib for the Treatment of Advanced Medullary Thyroid Cancer Outside a Clinical Trial: Results from a French Cohort
    Chougnet, Cecile N.
    Borget, Isabelle
    Leboulleux, Sophie
    de la Fouchardiere, Christelle
    Bonichon, Francoise
    Criniere, Lise
    Niccoli, Patricia
    Bardet, Stephane
    Schneegans, Olivier
    Zanetta, Sylvie
    Schvartz, Claire
    Drui, Delphine
    Chauffert, Bruno
    Rohmer, Vincent
    Schlumberger, Martin
    THYROID, 2015, 25 (04) : 386 - 391
12345